AzTrials
AzTrials

Intensive Care Unit SyndromeNCT06427265

Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study

An observational study of Intensive Care Unit Syndrome and Prediction, run by The Affiliated Hospital Of Guizhou Medical University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This project intends to track and evaluate whether post-ICU syndrome will occur 7 days, 1 month, 3 months and 6 months after ICU patients are transferred out of the ICU through a longitudinal study, apply the latent category growth model to identify different trajectory patterns of post-ICU syndrome in critically ill… Read more about this study

Who is it for?
Ages 18 to 100 yearsHealthy volunteers can take part
How many people
840 participants
Where
1 siteChina
Study dates
1 Dec 2023to 1 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Stage one involved studying patients discharged from the ICU and their families to investigate the occurrence and factors influencing post-intensive care syndrome (PICS), identifying various developmental patterns of PICS. A minimum sample size of 840 patients and 420 family members was established. Stage two focused on developing and evaluating a machine learning-based early warning model for PICS. The model construction utilized data from stage one, while the evaluation included 525 patients and 393 family members who met the exclusion criteria.

Who may be able to join

  • Length of stay in ICU ≥24h;
  • Age ≥18 years old;
  • Conscious when leaving ICU, communicating with investigators without barriers;
  • Informed consent. Family members:
  • One family member ≥18 years of age was selected for each patient;
  • Assume the main role of caring for patients and medical decision-making;
  • No history of mental illness or other serious organic diseases;
  • Informed consent and voluntary participation in this study.

Who cannot join

  • Have been in ICU for more than 24h within 3 months before this admission;
  • Transferred to another ICU;
  • Cognitive impairment existed before ICU admission (BDRS > 4 points);
  • Severe hearing impairment, dysarthria, etc., which cannot be followed up;
  • Unable to complete the questionnaire survey due to serious illness.
  • Family members:
  • Family members refuse to participate in the study due to their own reasons;
  • Severe hearing and language impairment, unable to cooperate with researchers.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, 550004

    Tingrui WANG, 19117899885, W19117899885@163.com

    Recruiting

Other trials in China

About this study

This project intends to track and evaluate whether post-ICU syndrome will occur 7 days, 1 month, 3 months and 6 months after ICU patients are transferred out of the ICU through a longitudinal study, apply the latent category growth model to identify different trajectory patterns of post-ICU syndrome in critically ill patients, and use modern machine learning models to build an early warning model of the trajectory patterns of post-ICU syndrome.

Keywords
Post-icu syndrome, Prediction model, Development Trajectory
Medical subject headings
Cognitive Dysfunction, Sleep Wake Disorders, Memory Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Correlation scale score

    Patient:

    1. Post-icu syndrome assessment of ICU survivors: Healthy Aging Brain Care monitoring(HABC Monitor) score;
    2. ICU related Memory: Intensive Care Unit Memory Tool (ICUMT);
    3. Sleep quality: Richards-Campbell Sleep Questionnaire (RCSQ);
    4. Perceived Social Support Scale (PSSS).

    Family members:

    1. Sleep quality of family members: Richards-Campbell Sleep Questionnaire (RCSQ);
    2. anxiety and Depression of family members: Hospital anxiety and Depression Scale score;
    3. Family fatigue: Scores of fatigue rating Scale;
    4. PTSD of family members: Event Impact Scale score;

    Measured: 2024-2026

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2024
  2. Study start1 Dec 2023
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion1 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
840 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06427265
Sponsor's protocol ID
ZHKYQ202316
Other IDs
No. ZHKYQ202316, No. Gyfynsfc[2023]35
Status last verified
Jun 2024
First submitted
19 May 2024
Last updated
31 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care Unit Syndrome and Prediction, run by The Affiliated Hospital Of Guizhou Medical University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tingrui WANG (19117899885, W19117899885@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Correlation scale score (time frame: 2024-2026). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in